The Global Prefilled Syringes Market Was Valued at USD 2.09 Billion in 2012 And is Expected to Grow at a CAGR of 13.3% From 2013 to 2019.

Transparency Market Research is Published new Market Report “Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," The global prefilled syringes market was valued at USD 2.09billion in 2012 and is expected to grow at a CAGR of 13.3% from 2013 to 2019, to reach an estimated value of USD 4.98billion in 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/prefilled-syringes-market.html

Prefilled syringes are advanced drug delivery devices filled with single measured dose of high-end injectable drugs. Thesesyringes are gradually becoming the most preferred delivery devices for various categories of injectable drugs, mainly due to the advantages offered to drug manufacturers, healthcare providers and patients over conventional vial and ampoule packaging systems. To drug manufacturers, they are important because they reduce overfill to 4%-5% from 20% in vials, and thus, are preferred for dispensing therapeutic classes (mainly biologics) which are expensive. With respect to healthcare providers and patients, prefilled syringes help with factors such as ease of operation, low risk of contamination and accurate dosing.

Glass has been the most preferred material over decades for syringe manufacturing, owing to its properties such as non-reactive nature, robustness, transparency and tolerability against heat. Consequently, glass based prefilled syringes accounted for the larger share(more than 90%) of the total market in 2012, both by revenue as well as volume.Sincethe past few years, the industry is witnessing a shift towards the usage of plastic in place of glass in response to some significant disadvantages associated with glass, such as high risk of breakability and increased level of leachability from silicone layer in the presence of biologics. Under the influence of continued development in the area of polymer technology, the market for plastic based syringes is expected to grow at a CAGR more than double of that of glass syringes duringthe forecast period from 2013 to 2019. Nevertheless, glass syringes will still dominate the total global market for prefilled syringes in 2019, in terms of percent share by revenue as well as volume.

Boost in the use of biologics and other potent injectable drugs, technical advances in prefilled syringe manufacturing and packaging, rising demand for self-administration and increasing elderly population suffering from various chronic diseases that require frequent parenteral dosing are some major drivers anticipated totrigger market growth during the forecast period. On the other hand, burgeoning concerns regarding needlestick safety and prevention, rising manufacturing costs and issues with drug stability are some of the challenges likely to affect the growth of the global prefilled syringes market.

Geographically, Europe constituted the largest market share for prefilled syringes in 2012, owing to the high adoption rate of these delivery devices in the region. However, the North American market is predicted to grow at a higher CAGR (15%) than Europe during the forecast period to reach a value similar to that of the European market. Major drivers expected to contribute to this market growth include increasing awareness regarding benefits of prefilled syringes and presence of a large number of biopharmaceuticals under clinical development targeted for parenteral administration. In addition, the high growth economies of emerging nations such as India, China, Brazil, Russia and Mexico are attracting manufacturers to invest in these lucrative markets. Japan is a well-established market for prefilled syringes among Asian countries.

The market for prefilled syringes is oligopolistic in nature and is dominated by a few key players, namely, Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG and Stevanato Group. Other vendors operating in the market include Unilife Corporation, West Pharmaceutical Services, Inc., Baxter International, Inc. and Ypsomed Holding AG.

The global prefilled syringes market is segmented as follows:

Prefilled Syringes Market, by Segment

• Glass Prefilled Syringes Market
• By Revenue (USD Million)
• By Volume (Million units)
• Plastic Prefilled Syringes Market
• By Revenue (USD Million)
• By Volume (Million units)

Prefilled Syringes Market, by Geography

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Blogs :

http://rahul28feb86.wordpress.com/

http://medicaldevicesnews.wordpress.com/

Global Aquaculture Market Will Reach USD 195.13 Billion By 2019 : Transparency Market Research

Transparency Market Research is Published new Market Report “Aquaculture (Marine Water, Freshwater and Brackish Water) Market for Carp, Molluscs, Crustaceans, Salmon, Trout and Other Fishes - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global market for aquaculture was valued at USD 135.10 billion in 2012 and is expected to reach USD 195.13 billion in 2019, growing at a CAGR of 5.1% from 2013 to 2019. In terms of volume, global production was 66.5 million tons in 2012 and is expected to grow at a CAGR of 2.3% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/aquaculture-market.html.

Volume of captured fish is fast depleting and is expected to be one of the primary factors driving global aquaculture production over the next few years. In addition, increasing consumer awareness regarding health benefits associated with consumption of fish and fish products is expected to boost aquaculture production within the forecast period. Aquaculture is expected to surpass captured fish industry as the major source for human consumption by the end of 2015. However, parameters such as adverse environmental conditions and lack of technology are expected to hamper the growth of the market. Increasing practice of rice and fish farming, which aims at increasing yields of rice grains as well as fishes is expected to open new opportunities for the growth of the market within the near future.

Aquaculture practiced in fresh water was the largest culture environment segment in 2012 accounting for over 60% of the production. It is expected to be one of the fastest growing segments over the next few years on account of simulation of the culture environment in enclosed areas such as ponds, cages and concrete raceways. Aquaculture practiced in marine water is expected to grow at a CAGR 2.4% from 2013 to 2019 on account of increased consumer demand for sea water fishes.

Carps were the biggest product segment within the market and accounted for over 35% of the global production in 2012. Carps, particularly common carps, have been one of the majorly farmed aquatic species in the industry owing to their compatibility in less than ideal environmental conditions. Mollusks such as clams and mussels have been an important food source and are expected to witness the fastest growth over the next few years. This segment is expected to grow at a CAGR of 2.6% from 2013 to 2019, owing to their increasingly use in poly culture systems such as rice and fish farming.

China dominated aquaculture production and accounted for over 60% of the total share in 2012. In addition, this region is expected to witness the fastest growth within the forecast period. Cheap labor, ease of availability of natural resources and induced conditions for aquaculture are some of the key factors which are expected to contribute significantly to the growth of the market in this region over the next few years.

The report gives a comprehensive view of the aquaculture market in terms of volume and revenue. In addition, the report includes current production analysis and forecast for each culture environment and product segment in North America, Europe, Asia Pacific (excluding China), China and Rest of the World (RoW). The report comprises of the following segments:

Aquaculture Market: Culture Environment Segment Analysis

• Freshwater
• Marine water
• Brackish water

Aquaculture Market: Product Segment Analysis

• Carps
• Mollusks
• Crustaceans
• Salmon
• Milkfish
• Trout
• Mackerel
• Sea Bream
• Sea Bass
• Others (Catfish and turbot)

The report provides a cross-sectional analysis of all the above product segments with respect to the following regions:

• North America
• Europe
• Asia Pacific (excluding China)
• China
• Rest of the World (RoW)

Related & Recently Published Reports by Transparency Market Research

• Biocides Market: http://www.transparencymarketresearch.com/global-biocides-market.html
• Medical Imaging Equipment Market:http://www.transparencymarketresearch.com/medical-imaging-equipment-market.html
• Personal and Entry Level Storage (PELS) Market:http://www.transparencymarketresearch.com/personal-entry-level-storage.html
• Global Camera Module Market: http://www.transparencymarketresearch.com/camera-module-market.html

 

Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research is Published new Market Report “Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” The global medical tourism market was valued at USD 10.5 billion in 2012 and is estimated to reach a market worth USD 32.5 billion in 2019 at a CAGR of 17.9% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/medical-tourism.html

Medical tourism is defined as an act of travel of patients from their home country to other destinations for availing medical services. Rise in healthcare costs in developed countries coupled with the availability of high quality medical services at a low cost in developing countries have given a boost to the medical tourism industry. These medical services range from elective procedures such as cosmetic surgeries to complicated surgeries such as cardiac, orthopedics, neurosurgery and others. Significant growth in this industry is due to economic developments in developing countries that in turn has led to the growth in the medical industry and quality of medical services.

Rise in the healthcare expenditure in developed countries coupled with in the growing elderly population has also contributed to the gowth of the medical tourism across the globe. Economic crisis in the U.S., increased the number of uninsured population, consequently further triggering the growth of this market. Recently, there are approximately 50 million uninsured Americans that are willing to travel abroad for affordable and quality medical care. Globalization and improved communication technology act as a catalyst to boost the growth of this industry.

The development of medical tourism industry is based on several factors such as reduced cost of procedures, long waiting time and high demand for cosmetic surgeries. Medical travel is not only witnessed for intricate procedures but is also expanding due to growing demand for cosmetic and dental procedures since these are usually not reimbursed under regular health insurance policies. Patients travelling abroad can save from 30% to 90% on a procedure, including their travel expenditures, as compared to the medical costs in their own countries. Long waiting time is another factor which has substantially boosted the growth of this industry. Patients based in Canada and U.K travel to low cost destinations for their treatments in order to avoid long waiting periods in their own countries and receive timely access to serious ailments.

Browse the full report PDF with TOC :  Medical Tourism Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Medical tourism industry is dominated by the Asian region that has captured the maximum share of the market. This region is highly competitive owing to the presence of technologically advanced medical specialties, less stringent government regulations and attractive locations. Thailand and India are recognized internationally for their high end medical services and receive patients from across the globe. Singapore is renowned for its healthcare infrastructure and receives patients primarily for complex medical procedures. Thailand, India and Singapore accounted for approximately 60% of the total revenue of the Asian region in 2012. The Latin American countries such as Brazil and Mexico attract maximum number of patients from the U.S owing to the geographic proximity and cultural similarities. Similarly, growth in Turkey is witnessed on account of growing demand of cosmetic surgeries.

Related & Recently Published Reports by Transparency Market Research

• Diagnostic Testing of STDs Market:http://www.transparencymarketresearch.com/diagnostic-testing-stds.html
• Clinical Laboratory Services Market : http://www.transparencymarketresearch.com/clinical-laboratory-services-market.html
• Anesthesia and Respiratory Devices Market : http://www.transparencymarketresearch.com/anesthesia-respiratory-devices.html

However, a paradigm shift in the market is seen owing to strong competition among the players of this industry. Malaysia is poised to have a significant growth in this market and is likely to emerge as a fastest growing country in terms of medical tourism with a CAGR of over 25% from 2013 to 2019. This advent in Malaysian medical tourism market is due to cost advantage over Thailand and Singapore. Moreover, rise in popularity of Malaysian region is attributed to many factors such as advanced healthcare infrastructure, highly skilled professionals, visa benefits and others. Additionally, robust government support for promotion of Malaysian medical tourism has propelled the growth in this nation.

Moreover, increase in the government initiatives and growing inclination of private sector hospitals towards medical tourism is further supplanting the growth of this market. Key healthcare providers in this industry include Apollo Hospitals Enterprise Ltd., Bumrumgrad International Hospital, Bangkok Medical Center, Prince Court Medical Center and others.

The Medical Tourism market is segmented as follows:

The global medical tourism market is segmented into the following categories:

• Medical Tourism Market, by Geography
• India
• Overview
• Cost Comparison of Procedures
• SWOT Analysis
• Government Support
• India Inbound Medical Tourism (No. of patients)
• India Medical Tourism: Top Revenue Contributing Country (%) (2012)
• Thailand
• Singapore
• Malaysia
• Mexico
• Brazil
• Turkey
• South Korea
• Taiwan
• Prospective Countries
• Costa Rica
• Poland
• Dubai
• Philippines

Blogs :

http://rahul28feb86.wordpress.com/

http://globalmarketresearchreports.quora.com/

http://rahul28feb.blogspot.kr/

http://medicaldevicesnews.wordpress.com/

Atrial Fibrillation Market Will Climb Above USD 14.8 Billion in 2019 : Transparency Market Research

Transparency Market Research is Published new Market Report “Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and Anti-Arrhythmic Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," . The global market for atrial fibrillation was valued at USD 6.1 billion in 2012 and it is expected to reach an estimated value of USD 14.8 billion in 2019, growing at a CAGR of 13.4% from 2013 to 2019.

Browse the full report with Complete TOC at http://www.transparencymarketresearch.com/atrial-fibrillation-market.html

Rising global base of geriatric population inducing an accelerated growth in the incidence rates of atrial fibrillation is one of the highest impact-rendering drivers for this market. In addition, favorable results exhibited by clinical trials promoting combined pharmacological therapy such as the HARMONY trial and rising prevalence of disorders causing atrial fibrillation such as hypertension and obesity will also serve the market as drivers. The future growth of this market will be ensured by the introduction of advanced treatment procedures such as hybrid ablation and the rising prevalence of atrial fibrillation in emerging Asian economies.

On account of the fact that pharmacological treatment procedures are more frequently administered to the patients suffering from atrial fibrillation and are a cheaper alternative to non-pharmacological procedures, pharmacological procedures held the majority of market share in 2012. With the introduction of new drugs such as Bristol Myer Squibb's NTC-801, Merck's Vernakalant, Boehringer Ingelheim's Pradaxa, the market share of pharmacological treatment procedures is expected to further increase by 2019.

The non-pharmacological treatment market was led by the catheter ablation market and its market share was valued at over 45% in 2012. The introduction of new catheter ablation systems such as CardioFocus's HeartLight Endoscopic Ablation System (EAS) laser ablation catheter, Endosense's TactiCath and Biosense Webster's ThermoCool SmartTouch, will help the catheter ablation market to further enhance its market share by 2019.

The radiofrequency based catheter ablation treatment for atrial fibrillation market led the catheter ablation market in terms of market share in 2012 majorly on account of the facts that it has a relatively lower procedural duration and cost and has high success rates associated with it.

High prevalence of atrial fibrillation coupled with the availability of high disposable incomes amongst patients and sophisticated healthcare infrastructure, has led the North American atrial fibrillation market to hold the majority of the market share in 2012. However, this region is expected to lose its market share to relatively faster growing Asia-Pacific region.

Some of the key players of this market include Boehringer Ingelheim, Bristol-Myers Squibb/Pfizer, Bayer/Johnson & Johnson, Medtronic, Inc., St. Jude Medical, Inc. and AtriCure, Inc.

The global atrial fibrillation market is categorized into the following segments:

• Atrial Fibrillation Market, by Treatment Types
• Pharmacological Treatment
• Anti-Arrhythmic Drugs
• Anti-Coagulant Drugs
• Non-Pharmacological Treatment
• Catheter Ablation
• Radiofrequency Based
• Cryoablation Based
• HIFU (High Intensity Focused Ultrasound) Based
• Microwave Based
• Laser Based
• Maze Surgery
• Electric Cardioversion
• Atrial Fibrillation Market, by Geography
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Blogs :

http://rahul28feb86.wordpress.com/

http://medicaldevicesnews.wordpress.com

Global Home Automation Market Will Reach USD 16.4 Billion By 2019: Transparency Market Research

This summary is not available. Please click here to view the post.